Gene: MAN1B1
Official Full Name: mannosidase alpha class 1B member 1provided by HGNC
Gene Summary: This gene encodes an enzyme belonging to the glycosyl hydrolase 47 family. This enzyme functions in N-glycan biosynthesis, and is a class I alpha-1,2-mannosidase that specifically converts Man9GlcNAc to Man8GlcNAc isomer B. It is required for N-glycan trimming to Man5-6GlcNAc2 in the endoplasmic-reticulum-associated degradation pathway. Mutations in this gene cause autosomal-recessive intellectual disability. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 11. [provided by RefSeq, Dec 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO31022 | MAN1B1 Knockout cell line (HeLa) | Human | MAN1B1 | 1:3~1:6 | Negative | Online Inquiry |
KO31023 | MAN1B1 Knockout cell line (HCT 116) | Human | MAN1B1 | 1:2~1:4 | Negative | Online Inquiry |
KO31024 | MAN1B1 Knockout cell line (HEK293) | Human | MAN1B1 | 1:3~1:6 | Negative | Online Inquiry |
KO31025 | MAN1B1 Knockout cell line (A549) | Human | MAN1B1 | 1:3~1:4 | Negative | Online Inquiry |
MAN1B1 Gene Knockout Cell Lines are specialized cellular models engineered to facilitate the study of the MAN1B1 gene, which encodes for the enzyme mannosidase I. This enzyme plays a crucial role in the N-glycosylation process, impacting protein folding, stability, and function, thereby influencing a variety of biological pathways. By creating knockout cell lines, researchers can investigate the effects of the absence of this specific gene, allowing for detailed insights into the underlying biochemical processes and disease mechanisms associated with impaired glycosylation.
These cell lines function by utilizing CRISPR/Cas9 gene-editing technology to precisely eliminate MAN1B1 expression. As a result, the cell lines exhibit altered glycosylation patterns, which can be observed and measured through various assays. This manipulation enables scientists to explore gene function, protein interactions, and the implications of disrupted glycosylation in certain diseases, including cancer, congenital disorders, and metabolic syndromes, significantly contributing to translational research and therapeutic development.
The scientific importance of MAN1B1 Gene Knockout Cell Lines lies in their capacity to mirror pathological conditions, providing an invaluable platform for drug discovery and biotechnology research. Unlike traditional cell lines with intact MAN1B1 expression, these knockout models offer unprecedented clarity in elucidating the gene's role and its potential as a therapeutic target.
Moreover, the unique selling points of these knockout cell lines include increased specificity and reliability in results, facilitated gene validation studies, and reduced variability in biological outcomes compared to wild-type lines. Their accessibility and cost-effectiveness position them as essential tools for both academic and industry-based laboratories focusing on glycosylation and its broader implications.
For researchers and clinicians aiming to enhance their understanding of glycoprotein biology, the MAN1B1 Gene Knockout Cell Lines represent a significant contribution to both basic and applied scientific inquiries. Backed by our company's dedication to innovation in genetic engineering and cell line development, these products reflect our expertise and commitment to providing cutting-edge solutions for the life sciences community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.